Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Mao Dongqing oral solution is a traditional Chinese medicine (TCM) product developed by Shangqiu Zhongsen Pharmaceutical Technology for the treatment of the common cold, specifically the wind-heat pattern. The formulation is centered on the extract of *Ilex pubescens* (Mao Dongqing), a plant known in TCM for its ability to clear heat, resolve toxins, and promote blood circulation. In clinical studies, the oral solution is evaluated for its efficacy in shortening the duration of cold symptoms such as fever, sore throat, and nasal congestion. It underwent Phase 2 clinical testing in China to determine optimal dosing and safety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound mao dongqing oral solution.